GABRQ Antibody - N-terminal region
Catalog Number:
ASB-ARP35283_P050
- Images (3)
| Article Name: | GABRQ Antibody - N-terminal region |
| Biozol Catalog Number: | ASB-ARP35283_P050 |
| Supplier Catalog Number: | ARP35283_P050 |
| Alternative Catalog Number: | ASB-ARP35283_P050-25UL,ASB-ARP35283_P050-100UL |
| Manufacturer: | Aviva |
| Host: | Rabbit |
| Category: | Proteine/Peptide |
| Application: | WB |
| Species Reactivity: | Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rabbit, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human GABRQ |
| Alternative Names: | THETA |
| The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, theta subunit. GABRQ gene is mapped to chromosome Xq28 in a cluster including the genes encoding the alpha 3 and epsilon subunits of the same receptor. This gene location is also the candidate region of 2 different neurologic diseases:early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (MRX3).The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, theta subunit. It is mapped to chromosome Xq28 in a cluster including the genes encoding the alpha 3 and epsilon subunits of the same receptor. This gene location is also the candidate region of 2 different neurologic diseases: early-onset parkinsonism (Waisman syndrome) and X-linked mental retardation (MRX3). |
|
|
WB Suggested Anti-GABRQ Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:12500 Positive Control: Jurkat cell lysate |
|
|
Host: Rabbit Target Name: GABRQ Sample Tissue: Human Stomach Tumor Antibody Dilution: 1.0ug/ml |
|
|
GABRQ antibody - N-terminal region (ARP35283_P050) in Human Stomach Tumor using Western Blot |
Product Guarantee and Expert Support
